Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial
- 31 October 2011
- journal article
- research article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 11 (10), 741-749
- https://doi.org/10.1016/s1473-3099(11)70100-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trialThe Lancet Infectious Diseases, 2011
- Evaluation of the Safety and Immunogenicity of the RTS,S/AS01EMalaria Candidate Vaccine When Integrated in the Expanded Program of ImmunizationThe Journal of Infectious Diseases, 2010
- Evidence of decline of malaria in the general hospital of Libreville, Gabon from 2000 to 2008Malaria Journal, 2009
- Epidemiology of malaria in the forest-savanna transitional zone of GhanaMalaria Journal, 2009
- Development and Technical and Clinical Validation of a Quantitative Enzyme-Linked Immunosorbent Assay for the Detection of Human Antibodies to Hepatitis B Surface Antigen in Recipients of Recombinant Hepatitis B Virus VaccineClinical and Vaccine Immunology, 2009
- Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of ProtectionThe Journal of Infectious Diseases, 2009
- Long‐Term Safety and Efficacy of the RTS,S/AS02A Malaria Vaccine in Mozambican ChildrenThe Journal of Infectious Diseases, 2009
- Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in InfantsThe New England Journal of Medicine, 2008
- Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of AgeThe New England Journal of Medicine, 2008
- Malaria: progress, perils, and prospects for eradicationJCI Insight, 2008